N-isopropyl-carbamic acid cyclohexyl ester

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-isopropyl-carbamic acid cyclohexyl ester
• 英文别名: cyclohexyl N-propan-2-ylcarbamate
• 化学式: C₁₀H₁₉NO₂
• 分子量: 185.266
• InChiKey: HJDKDBZBAJJYTJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  N-丙烷-2-基甲酰胺 、 环己醇 在 [bis({2-[bis(propan-2-yl)phosphanyl]ethyl})amide](carbonyl)(hydride)iron(II) 作用下， 以 甲苯 为溶剂， 以72 %的产率得到N-isopropyl-carbamic acid cyclohexyl ester
  参考文献：
  名称：

  使用钳载铁催化剂从甲酰胺和醇脱氢合成氨基甲酸酯

  摘要：

  我们报告了钳形连接的铁络合物 ( iPr PNP)Fe(H)(CO) [ 1 , iPr PNP – = N(CH 2 CH 2 P i Pr 2 ) 2 – ] 是脱氢合成的活性催化剂来自甲酰胺和醇的 N-烷基和 N-芳基取代的氨基甲酸酯。该反应与工业相关的 N-烷基甲酰胺、N-芳基甲酰胺以及 1°、2° 和苄醇兼容。机理研究表明，反应的第一步是甲酰胺脱氢为瞬态异氰酸酯1. 然后异氰酸酯与醇反应生成氨基甲酸酯。然而，在竞争反应中，异氰酸酯与1发生可逆的环加成反应，生成非循环物质，这是催化中的静止状态。化学计量实验表明催化需要高温以促进异氰酸酯从环加成产物中释放。我们还鉴定了发生在催化几个其它非周期进程，如1,2-加成的甲酰胺或醇底物的跨中的Fe-N键1. 已经证明，甲酰胺脱氢产生的瞬时异氰酸酯可以被胺捕获以形成脲，并且原则上异氰酸酯也可以被硫醇捕获以形成硫代氨基甲酸酯。竞争实验表明，用胺

  DOI：

  10.1021/acscatal.1c02718

文献信息

• [EN] INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY<br/>[FR] INHIBITEURS D'ACTIVITÉ DE PROTÉINE TYROSINE KINASE
  申请人：METHYLGENE INC

  公开号：WO2009109035A1

  公开（公告）日：2009-09-11

  This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions.

  本发明涉及抑制蛋白质酪氨酸激酶活性的化合物。特别是，本发明涉及抑制生长因子受体的蛋白质酪氨酸激酶活性的化合物，从而抑制受体信号传导，例如抑制VEGF受体信号传导。本发明还提供了用于治疗细胞增殖性疾病和状况以及眼科疾病、障碍和状况的化合物、组合物和方法。
• Inhibitors of Protein Tyrosine Kinase Activity
  申请人：Raeppel Stëphane

  公开号：US20110257100A1

  公开（公告）日：2011-10-20

  This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and ophthalmic diseases, disorders and conditions.

  本发明涉及抑制蛋白酪氨酸激酶活性的化合物。特别是，本发明涉及抑制生长因子受体的蛋白酪氨酸激酶活性的化合物，从而抑制受体信号传导，例如，抑制VEGF受体信号传导。本发明还提供了用于治疗细胞增殖性疾病和条件以及眼科疾病、障碍和条件的化合物、组合物和方法。
• URACIL DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES
  申请人：Shiro Tomoya

  公开号：US20140179670A1

  公开（公告）日：2014-06-26

  The present invention provides: an uracil derivative represented by general formula (I) or a physiologically acceptable salt thereof (in the formula, R 1 represents a hydrogen atom, a C 1-10 alkyl group, a C 2-6 alkene group or a 3- to 6-membered saturated or 4- to 6-membered unsaturated aliphatic ring group which may contain 1 to 2 hetero atoms independently selected from the group consisting of N, O and S; R 2 represents a hydrogen atom, a halogen atom, a cyano group, —NR c R d , —N═CHN(CH 3 ) 2 , or an C 1-3 alkyl group; Ar 1 and Ar 2 independently represent a 5- to 6-membered aromatic ring group which may contain 1 to 3 hetero atoms independently selected from the group consisting of N, O and S; and L represents a 6-membered aromatic ring group which may contain 1 to 4 nitrogen atoms, a pyrazole group, a triazole group, or an imidazole group); and a therapeutic agent or prophylactic agent for various inflammatory diseases associated with elastase, comprises the compound or the like as an active ingredient.

  本发明提供：一种尿嘧啶衍生物，其由通式（I）表示，或其生理上可接受的盐（在该式中，R1代表氢原子，C1-10烷基，C2-6烯基或3-至6-成员饱和或4-至6-成员不饱和的脂肪环基，该环基可以独立地选择来自N，O和S的1到2个杂原子；R2代表氢原子，卤素原子，氰基，—NRcRd，—N═CHN(CH3)2或C1-3烷基；Ar1和Ar2独立地表示5-至6-成员芳香环基，该环基可以独立地选择来自N，O和S的1到3个杂原子；L表示6-成员芳香环基，该环基可以包含1到4个氮原子，吡唑基，三唑基或咪唑基）；以及用作与弹性酶相关的各种炎症性疾病的治疗剂或预防剂，包括该化合物或类似物作为活性成分。
• INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE ("NACK") AND METHODS FOR USE OF THE SAME
  申请人：UNIVERSITY OF MIAMI

  公开号：US20210171469A1

  公开（公告）日：2021-06-10

  Disclosed herein are Notch transcriptional activation complex kinase (“NACK”) inhibitors, and methods for their use in treating or preventing diseases, such as cancer. The inhibitors described herein include compounds of Formula (la) and pharmaceutically acceptable salts thereof: wherein the substituents are as described.
• US4146550A
  申请人：——

  公开号：US4146550A

  公开（公告）日：1979-03-27